Lewis C. Cantley

Lewis C. Cantley is an American cell biologist and is currently the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, and the Margaret and Herman Sokol Professor in Oncology Research. He is best known for his discovery of the enzyme PI 3-kinase and its role in regulating cell growth and metabolism, as well as for his contributions to the development of targeted cancer therapies.

Lewis C. Cantley obtained his Bachelor of Science degree in chemistry from West Virginia Wesleyan College in 1971. He then went on to earn his Ph.D. in biophysical chemistry from Cornell University in 1975.

Lewis C. Cantley is known for his discovery of the enzyme PI 3-kinase in 1984, which has had significant implications in the field of cell biology and cancer research. His research on PI 3-kinase led to a better understanding of how cells regulate their growth and metabolism. He has also made significant contributions to the development of targeted cancer therapies, such as PI 3-kinase inhibitors, which have shown promise in the treatment of certain types of cancer.

Lewis C. Cantley currently serves as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. He is also the Margaret and Herman Sokol Professor in Oncology Research at Weill Cornell Medicine. In addition, he is a member of the National Academy of Sciences and the National Academy of Medicine.

Lewis C. Cantley's research is primarily focused on understanding the molecular mechanisms that drive cell growth, metabolism, and cancer development. He is particularly interested in the role of the PI 3-kinase pathway in these processes and has made significant contributions to our understanding of its function. His work has led to the development of targeted therapies for cancer that aim to block the PI 3-kinase pathway.